1999
DOI: 10.1136/gut.44.2008.s1
|View full text |Cite
|
Sign up to set email alerts
|

An evidence-based appraisal of reflux disease management --- the Genval Workshop Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

13
620
2
90

Year Published

2001
2001
2010
2010

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 769 publications
(725 citation statements)
references
References 112 publications
13
620
2
90
Order By: Relevance
“…3 Best outcomes are achieved with these aims by the use of a proton pump inhibitor. The increment of efficacy of esomeprazole over other proton pump inhibitors further enhances the opportunities for achieving excellent results in this first phase of reflux disease management.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…3 Best outcomes are achieved with these aims by the use of a proton pump inhibitor. The increment of efficacy of esomeprazole over other proton pump inhibitors further enhances the opportunities for achieving excellent results in this first phase of reflux disease management.…”
Section: Discussionmentioning
confidence: 99%
“…Fortunately, reflux-induced symptoms are quite distinctive in their patterning in a substantial majority of patients with reflux disease, as other diagnostic options are unsuitable for routine initial management ) endoscopy being relatively insensitive and oesophageal pH-monitoring being impractical as a Ôfront-lineÕ test. 3 Both of these diagnostic tests are also relatively costly and frequently difficult to access promptly. As initial therapy is usually prescribed on the basis of symptom evaluation, relief of symptoms by therapy is the best possible confirmation of this diagnosis.…”
Section: Aims Of Initial Treatmentmentioning
confidence: 99%
See 3 more Smart Citations